Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNPSN.L Regulatory News (NPSN)

  • There is currently no data for NPSN

Trading Statement

16 Nov 2020 15:50

RNS Number : 4774F
Naspers Limited
16 November 2020
Β 

Naspers Limited

(Incorporated in the Republic of South Africa)

(Reg. No 1925/001431/06)

JSE Share Code: NPN ISIN: ZAE000015889

LSE ADS Code: NPSN ISIN: US6315122092

("Naspers")

Β 

Trading statement

Β 

Shareholders are advised that the Naspers group ("the group") is finalising its condensed consolidated interim report for the six months ended 30 September 2020.

As outlined in the table below, the Group is expected to deliver good results for the first half ended 30 September 2020 despite the impacts of Covid-19.

We have completed several acquisitions in the first six months and have continued to explore growth opportunities to advance our strategy, expand our ecosystem and to position the business for continued long-term growth.

More details will be published with the condensed consolidated interim financial statements on Monday, 23 November 2020.

The group has illustrated the anticipated changes in earnings, headline earnings and core headline earnings per share for the period ended 30 September 2019 as compared to 30 September 2020 in the tables below:

30 September 2019

US cents

30 September 2020

expected increase/(decrease)

US cents

Expected increase/(decrease) %

Earnings per share(1)

518

(34) - 3

(6.6%) - 0.6%

Headline earnings per share(1)

326

67 - 89

20.6% - 27.3%

Core headline earnings* per share(1)

380

(28) - (5)

(7.4%) - (1.3%)

For the period ended 30 September 2020, the group's earnings, headline earnings and core headline earnings growth is impacted largely by reduced earnings contributions in the current year from the Prosus Group, post its listing in September 2019 and the creation of the free-float resulting in a significant non-controlling interest of the group. As at 30 September 2019 we recognised 100% of the Prosus earnings compared to 72.66% in the current period. The expected non-controlling interest share in the core headline earnings for the period would be approximately US$600m. We refer shareholders to the separate Prosus trading statement which is free of the impacts outlined in this paragraph and outlines expected increases in headline earnings and core headline earnings of the group's operations. We remind shareholders that Prosus represents the majority of the group's operations.

Shareholders are reminded that the board considers core headline earnings an appropriate indicator of the operating performance of the group, as it adjusts for non-operational items. Core headline earnings per share for the current period is expected to decrease by between 28 and 5 cents per share (between 7.4% and 1.3%), driven mainly by the creation of the Prosus free float in September 2019 as described above. Adjusted for this, core headline earnings growth per share is expected to increase in the same range as Prosus, between 23.8% - 30.5%, as illustrated in the Prosus trading statement.

Like most companies, in the period we faced some challenges due to Covid-19, particularly in countries where government lockdown regulations were wide ranging and long lasting. However, we have seen a sharp recovery in all of our impacted businesses as our contingency plans produced results once lockdown regulations began easing. We continue to respond quickly to the evolving Covid-19 situation to ensure we safeguard our people, maintain our ability to serve our customers and protect our businesses for the long-term. While forward visibility remains difficult, given the challenges some countries face in dealing with the longer-term effects of Covid-19, we continue to believe we will benefit from the acceleration of the trends that have propelled the growth of the consumer internet.

Financial information on which this trading statement is based has not been reviewed or reported on by the company's auditors.

Β 

JSE sponsor (South Africa): Investec Bank LimitedΒ 

Cape TownΒ 

16 November 2020

Β 

* Core headline earnings, a non-IFRS performance measure, represent headline earnings for the period, excluding certain non-operating items. Specifically, headline earnings are adjusted for the following items to derive core headline earnings: (i) equity-settled share-based payment expenses on transactions where there is no cash cost to the company. These include those relating to share-based incentive awards settled by issuing treasury shares as well as certain share-based payment expenses that are deemed to arise on shareholder transactions; (ii) deferred taxation income recognised on the first-time recognition of deferred tax assets, as this generally relates to multiple prior periods and distorts current period performance; (iii) fair-value adjustments on financial instruments and unrealised currency translation differences, as these items obscure the group's underlying operating performance; (iv) once-off gains and losses (including acquisition-related costs) resulting from acquisitions and disposals of businesses, as these items relate to changes in the composition of the group and are not reflective of its underlying operating performance; and (v) the amortisation of intangible assets recognised in business combinations and acquisitions and (vi) donations made to various governments in assisting with the Covid-19 pandemic, as these expenses are not considered operational in nature. These adjustments are made to the earnings of combined businesses controlled by the group as well as the group's share of earnings of associates and joint ventures, to the extent that the information is available.

(1) Per share information is based on the net number of A and N ordinary shares in issue during the respective periods.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTKKABDPBDDBDD
Date   Source Headline
29th Sep 20097:00 amRNSACQUISITION OF BRAZILIAN E-COMMERCE OPERATOR Busca
10th Sep 20094:00 pmRNSDirector's dealing in shares
10th Sep 20094:00 pmRNSDirectors dealing in shares
10th Sep 20094:00 pmRNSDirectors dealing in shares
9th Sep 20094:09 pmRNSDirectors dealing in shares
4th Sep 200911:34 amRNSDirectorate Change
1st Sep 200910:00 amRNSDirectors dealing in shares
1st Sep 200910:00 amRNSDirectors dealing in shares
28th Aug 200911:13 amRNSResult of AGM
25th Aug 200911:25 amRNSAnnual Information Update
30th Jul 20094:00 pmRNSNo change announcement
6th Jul 20095:00 pmRNSDirectors dealings
30th Jun 20097:00 amRNSDividend Declaration
30th Jun 20097:00 amRNSFinal Results
18th Jun 20091:30 pmRNSTrading Statement
10th Jun 20091:29 pmRNSAcquisition
1st Apr 200910:00 amRNSDirectorate Change
27th Feb 20093:11 pmRNSDirector/PDMR Shareholding
13th Feb 20093:00 pmRNSDirector/PDMR Shareholding
15th Dec 20083:00 pmRNSDirector's dealings
26th Nov 20087:00 amRNSInterim Results
12th Nov 200812:30 pmRNSTrading Statement
10th Nov 200812:00 pmRNSDisposal
25th Sep 20088:48 amRNSDirector's dealing in shares
25th Sep 20088:42 amRNSDirector's dealings in shares
28th Aug 200810:00 amRNSAnnual Information Update
28th Aug 20088:48 amRNSDisposal
26th Aug 200811:59 amRNSDirectorate Change
22nd Aug 20081:00 pmRNSAGM Statement
22nd Aug 20081:00 pmRNSDividend Declaration
30th Jul 20089:30 amRNSNotice of AGM
30th Jul 20089:07 amRNSDirector major sub trade in s
24th Jul 20084:05 pmRNSDirector's dealing in securit
30th Jun 20088:00 amRNSDisposal
25th Jun 20088:00 amRNSDividend Declaration
25th Jun 20088:00 amRNSFinal Results
23rd Jun 20083:30 pmRNSCompany Secretary Change
11th Jun 20082:08 pmRNSTrading Statement
4th Jun 20082:47 pmRNSDisposal
2nd Jun 200812:00 pmRNSDisposal
23rd Apr 20088:00 amRNSDisposal
15th Apr 20088:00 amRNSDisposal of NetMed N.V.
1st Apr 20084:33 pmRNSDirectorate Change
13th Mar 20083:30 pmRNSDealing in securities
13th Mar 20082:40 pmRNSDealing in securities
13th Mar 20082:39 pmRNSDealing in securities
7th Mar 200811:30 amRNSCash offer for Tradus plc
29th Feb 20083:07 pmRNSDealing in securities
18th Dec 20077:18 amRNSOffer for Tradus PLC
27th Nov 20078:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.